top of page

Dr. Lazuk Biotics

Dr. Lazuk Cosmetics

Lazuk Esthetics

Dr Lazuk Nutrition

Home
About
Contact - contact@skindoctor.ai

Facebook - Dr Lazuk Cosmetics

Facebook - Lazuk Esthetics

BlueSky - @skindoctor.bsky.social
LinkedIn - Hihikats International Inc

Hihikats® International Inc | 2423 SW 147TH AVE #772, Miami, FL 33185

© 2026 by SkinDoctor AI®

SkinDoctor.ai — Technical Whitepapers

8. Barrier, Inflammation & Microenvironment Impact
Barrier Integrity
 

  • Reduced TEWL compared to aggressive cleansers

  • Preservation of lipid lamellae

  • Improved tolerance to downstream actives
     

Inflammatory Baseline

  • Lower incidence of post-wash erythema

  • Reduced cumulative irritation over time
     

Microenvironment

  • Does not aggressively alter surface microbiota

  • Avoids prolonged pH disruption
     

9. Use-Case Stratification
Ideal For

  • Sensitive or reactive skin

  • Acne-prone skin under corrective protocols

  • Post-procedure recovery phases

  • Dehydrated or barrier-compromised skin
     

Acceptable For

  • Normal and combination skin seeking low-interference cleansing
     

Not Intended For

  • Heavy makeup or waterproof sunscreen removal (requires pre-cleanse)

  • Users seeking strong degreasing or exfoliation
     

10. Protocol Integration

  • Clarité™ Protocol – Primary cleanser for barrier stabilization

  • Serein™ Protocol – Daily resilience and prevention support

  • Radiant Protocol – Prevents cleanser-induced irritation during correction

  • LUXE Renewal Protocol – Recovery-safe cleansing during regenerative care
     

In all protocols, the cleanser functions as infrastructure, not an outcome driver.

11. Misuse, Limitations & Risk Management

Common Misuse

  • Over-cleansing (>2× daily)

  • Mechanical scrubbing

  • Expecting exfoliation or acne treatment
     

Limitations

  • Will not create a “squeaky clean” sensation

  • Will not correct pathology

  • Will not remove heavy occlusives alone
     

Risk Profile

Low. Barrier compromise remains possible if paired with excessive exfoliation or inappropriate actives.

12. Regulatory & Claims Boundary
 

  • Cosmetic classification only

  • No disease treatment or prevention claims

  • No alteration of skin structure or function beyond appearance and comfort
     

Claims remain mechanistic and supportive.

13. AI Diagnostic & Decision-Support Alignment

Within AI-assisted skin analysis systems, this cleanser aligns with signals indicating:

  • Barrier compromise

  • Sensitivity and reactivity

  • Low tolerance for actives
     

It is typically recommended when stabilization is prioritized over correction.

14. Conclusion: Role Within a Systems-Based Skincare Model

The Beneficial Face Cleanser with Centella Asiatica (Dermo Complex) is intentionally restrained. Its value lies not in visible transformation, but in preventing invisible damage that destabilizes every step that follows.

In a dermatology-led skincare system, this cleanser serves as foundational infrastructure—quiet,
conservative, and essential.

Beneficial Face Cleanser with Centella Asiatica (Dermo Complex)
Dr. Lazuk Cosmetics®

1. Executive Technical Overview

The Beneficial Face Cleanser with Centella Asiatica (Dermo Complex) is a dermatology-formulated, low-interference cleansing system designed to remove environmental and sebaceous contaminants while preserving epidermal barrier architecture and inflammatory equilibrium.

This formulation was intentionally engineered not as a corrective or exfoliating cleanser, but as a barrier-preserving interface within a systems-based skincare model. Its clinical objective is to reduce cumulative physiologic damage associated with daily cleansing—damage that often precedes and undermines the effectiveness of corrective skincare and in-clinic treatments.

2. Formulator & Clinical Context

This product was developed under the direction of Dr. Iryna Lazuk, MD, a physician with formal medical education, postgraduate dermatology training, and extensive clinical experience in dermatology and aesthetic medicine.

Through years of direct patient care in multidisciplinary medical settings, Dr. Lazuk repeatedly observed that:

Chronic sensitivity, acne persistence, dehydration lines, and post-procedure irritation were frequently not caused by treatment failure, but by daily barrier disruption.

Cleansers—particularly foaming or aggressively degreasing formulations—were a consistent, under-recognized source of low-grade inflammatory injury.

Patients often failed to tolerate otherwise appropriate active therapies because their baseline cleansing step destabilized the skin before treatment even began.

The formulation logic of this cleanser reflects a clinical decision to reduce harm before attempting correction, prioritizing predictability and tolerance over immediate sensory feedback.

3. Product Classification & Intended Use

Classification
Daily facial cleanser (rinse-off cosmetic)

Intended Use

  • Removal of surface contaminants (sebum, particulate pollution, debris)

  • Preservation of stratum corneum lipid organization

  • Reduction of post-cleansing irritation

  • Preparation of skin for protocol-based care

Explicit Exclusions

  • Not intended to treat acne, dermatitis, rosacea, or infection

  • Not intended to exfoliate or resurface skin

  • Not intended to alter skin structure or physiology beyond cosmetic support

4. Dermatologic Problem Space Addressed

Modern skincare failure is frequently driven by over-cleansing rather than under-cleansing.

Repeated surfactant exposure has been shown to:

  • Extract intercellular lipids

  • Disrupt corneocyte cohesion

  • Increase transepidermal water loss (TEWL)

  • Amplify inflammatory signaling

  • Reduce tolerance to actives and procedures

This cleanser addresses a narrow but critical problem space:

 

how to cleanse skin without destabilizing the barrier or inflammatory baseline.

5. Full Ingredient Disclosure (INCI)

INCI List


Water, Glycerin, Cocamidopropyl Betaine, Sodium Lauroyl Sarcosinate, Decyl Glucoside, Acrylates Copolymer, Xanthan Gum, Centella Asiatica Extract, 1,2-Hexanediol, Salicylic Acid, Citric Acid, Titanium Dioxide, Madecassoside

6. Ingredient Architecture & Functional Categorization

6.1 Cleansing System (Surfactants)

  • Cocamidopropyl Betaine – Amphoteric surfactant; reduces irritation potential of primary cleansers

  • Sodium Lauroyl Sarcosinate – Mild anionic surfactant with lower lipid extraction than sulfates

  • Decyl Glucoside – Non-ionic surfactant; supports gentle soil removal

Design Rationale


This blended surfactant system lowers the critical micelle concentration and limits deep lipid solubilization, reducing barrier disruption compared to single-surfactant systems.

6.2 Barrier & Hydration Support

  • Glycerin – Humectant; mitigates immediate post-rinse dehydration

  • Xanthan Gum / Acrylates Copolymer – Rheology modifiers that stabilize contact time without aggressive foaming

6.3 Active Dermatologic Components

Centella Asiatica Extract

Centella Asiatica provides bioactive triterpenoids known to:

  • Modulate inflammatory mediator release

  • Support fibroblast signaling

  • Improve epidermal recovery after irritation

Rationale in a Cleanser


Although rinse-off exposure is brief, repeated daily use allows cumulative reduction of cleansing-induced inflammatory signaling.

Madecassoside

A purified Centella derivative with:

  • Barrier-supportive effects

  • Anti-irritant activity

  • Relevance even at low contact durations

Design Choice


Included to counteract unavoidable micro-irritation from surfactant exposure rather than to act as a treatment active.

6.4 Auxiliary Components

  • Salicylic Acid – Present at low, supportive concentration for mild pore-clearing without exfoliation

  • Citric Acid – pH adjustment

  • 1,2-Hexanediol – Preservative support

  • Titanium Dioxide – Opacifier (non-functional dermatologic role)

7. Mechanism of Action (Physiologic Level)

The cleanser operates through interference minimization, not correction:

  1. Selective Contaminant Removal
    Removes surface debris while preserving intercellular lipids.

  2. Inflammatory Dampening
    Centella-derived compounds reduce keratinocyte stress signaling triggered during cleansing.

  3. Barrier Recovery Enablement
    By limiting corneocyte disorganization, the skin can normalize more rapidly post-rinse.

Explore

Our Approach

How It Works

Success Stories

FAQs

Learn

Blog Home

Understanding Your Skin

Ingredient Education

Treatment Education

Nutrition Education

Esthetics

Services Overview

Injectables

Laser treatments

Roller Massage Therapy

Luxury Beauty Facials

Hihikats® International Inc | 2423 SW 147TH AVE #772, Miami, FL 33185 

Dr. Lazuk Cosmetics® | Lazuk Esthetics® | Lazuk Biotics® | Lazuk Nutrition®

© 2026 by SkinDoctor AI®

bottom of page